Objective: Despite the fact that the total energy intake of Japanese people
has decreased, the percentage of obese people has increased. This suggests that the timing
of meals is related to obesity. The purpose of the study was to investigate the
relationship between the timing of meals and obesity, based on analyses of physical
measurements, serum biochemical markers, nutrient intake, and lifestyle factors in the
context of Chrononutrition.Participants and Methods: We analyzed data derived from 766 residents of
Toon City (286 males and 480 females) aged 30 to 79 years who underwent detailed medical
examinations between 2011 and 2013. These medical examinations included. (1) physical
measurements (waist circumference, blood pressure, etc.); (2) serum biochemical markers
(total cholesterol, etc.); (3) a detailed questionnaire concerning lifestyle factors such
as family structure and daily habits (22 issues), exercise and eating habits (28 issues),
alcohol intake and smoking habits; (4) a food frequency questionnaire based on food groups
(FFQg); and (5) a questionnaire concerning the times at which meals and snacks are
consumed.Results: The values for body mass index (BMI) and waist circumference were
higher for participants who ate dinner less than three hours before bedtime (<3-h
group) than those who ate more than three hours before bedtime (>3-h group). The
Chi-square test showed that there was a significant difference in eating habits, e.g.,
eating snacks, eating snacks at night, having dinner after 8 p.m., and having dinner after
9 p.m., between the <3-h group and the >3-h group. Multiple linear regression
analysis showed that skipping breakfast significantly influenced both waist circumference
(β = 5.271) and BMI (β = 1.440) and that eating dinner <3-h before going to bed only
influenced BMI (β = 0.581).Conclusion: Skipping breakfast had a greater influence on both waist
circumference and BMI than eating dinner <3-h before going to bed.
The effect of the benzylic structure of lignan on antioxidant activity was evaluated. Secoisolariciresinol (1) and 3,4-bis(4-hydroxy-3-methoxybenzyl)tetrahydrofuran (2), which have two secondary benzylic positions without oxygen, showed the highest antioxidant activity. Optically active verrucosin (4) was synthesized for the first time in this experiment.
Fish protein is a source of animal protein that is consumed worldwide. Although it has been reported that the intake of Alaska pollack protein (APP) reduces serum triglyceride and body fat accumulation in rats, the mechanisms underlying these effects are poorly understood. In the present study, we fed 5-week-old male Sprague-Dawley rats a high-fat diet with APP or casein for 4 weeks. We reconfirmed that the intake of APP decreases serum triglycerides and inhibits visceral body fat accumulation in rats. We found that APP had a higher non-digestive protein content than casein, and the amount of protein in feces was higher in the APP group than in the casein group. However, the amount of total lipids in feces did not differ significantly between the groups. We also found that the gastrocnemius muscle, a fast-twitch muscle, tended to increase in weight, and that the epididymal fat weight correlated negatively with gastrocnemius muscle weight in the APP group. These results imply that the enhancement of basal energy expenditure by fast-twitch muscle hypertrophy, rather than the enhancement of lipid excretion via feces, partly causes APP-induced inhibition of lipid accumulation in rats.
(2015) Fish protein intake induces fast-muscle hypertrophy and reduces liver lipids and serum glucose levels in rats, Bioscience, Biotechnology, and Biochemistry, 79:1, 109-116,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.